FDA Approves Durezol (difluprednate) for Ocular Surgery Inflammation and Endogenous Anterior Uveitis
FDA approves Durezol eye drops for inflammation and pain after eye surgery and uveitis.
The FDA approved difluprednate ophthalmic emulsion (Durezol) for treating inflammation and pain after ocular surgery and for endogenous ante…
The FDA has approved Durezol eye drops to treat inflammation and pain after eye surgery, and also for a condition called anterior uveitis. T…
Portable visual-field testing devices show 86% sensitivity and 88% specificity for glaucoma diagnosis
Portable devices show promise for diagnosing glaucoma more quickly
This meta-analysis of 2,254 participants with glaucoma and controls evaluated the diagnostic accuracy of portable visual-field testing devic…
New research suggests portable vision tests can accurately detect glaucoma while significantly cutting down the time patients spend in testi…
Unadjusted hazard ratio of 2.14 for mortality in primary open-angle glaucoma patients
Understanding the link between glaucoma and overall health risks for patients
This meta-analysis evaluates the mortality risk associated with various types of glaucoma, including POAG, PACG, and congenital glaucoma. Th…
A large review shows that people with certain types of glaucoma may face higher health risks, highlighting the need for full-body care.
GWAS meta-analysis identifies 18 genetic loci for dermatochalasis, 16 novel
Genetic Research Identifies New Links to Skin Sagging and Aging Traits
This meta-analysis of genome-wide association studies across three biobanks identified 18 genetic loci associated with dermatochalasis, 16 o…
Scientists found specific genes linked to skin sagging. This helps experts understand how our DNA affects the way skin ages over time.
Glaucoma prevalence in Africa varies widely with diagnostic criteria; standardized ISGEO definitions narrow estimates
Standardized rules help track how common glaucoma is in Africa
This systematic review of 9 population-based studies in Africa found that glaucoma prevalence estimates range from 4.3% to 5.3% when using f…
Using consistent diagnostic rules for glaucoma helps doctors get a clearer picture of how many people are affected across different regions.
Central 2.50-mm geographic atrophy extent correlates with visual function measures in age-related macular degeneration
Central vision loss impacts daily life for geographic atrophy patients
This observational analysis of Phase III clinical trial data involved 856 individuals aged 50 years or more with bilateral geographic atroph…
New analysis shows that damage in the very center of the eye most affects how people with geographic atrophy experience their daily lives.
Telemedicine achieves 0.93 to 0.97 sensitivity and specificity for screening retinopathy of prematurity
Telemedicine Shows High Accuracy for Screening Retinopathy of Prematurity
This meta-analysis evaluates the performance of telemedicine technology for identifying referral-warranted (RW) and treatment-required (TR) …
New data shows telemedicine tools can accurately identify eye conditions in premature infants, potentially helping babies in remote or low-r…
Gene therapy significantly reduces central subfield thickness in neovascular age-related macular degeneration
Gene Therapy Shows Potential to Reduce Swelling in Macular Degeneration
This meta-analysis of early-phase trials evaluates gene therapy for neovascular age-related macular degeneration. While a significant anatom…
New gene therapy research shows significant reduction in retinal swelling for patients with neovascular age-related macular degeneration.
Systemic C-reactive protein levels show no significant association with central serous chorioretinopathy
CRP Levels Show No Link to Central Serous Chorioretinopathy
This meta-analysis of 544 patients with CSC and 655 controls found no statistically significant difference in systemic CRP levels (95% CI: -…
New analysis suggests that systemic C-reactive protein levels are not linked to the eye condition central serous chorioretinopathy.
Faricimab 6 mg every sixteen weeks outperforms aflibercept and ranibizumab in ARMD visual acuity
Faricimab shows better vision outcomes for age related macular degeneration
This meta-analysis of 8 studies involving 8458 study populations found that faricimab 6 mg every sixteen weeks showed superior effects on be…
A new treatment option for age related macular degeneration may offer better vision and thinner retinal tissue than current standard drugs.
Carbonic anhydrase inhibitors and DEXi show superior CMT reduction in retinitis pigmentosa macular oedema
New Analysis Compares Treatments for Retinitis Pigmentosa Macular Oedema
This network meta-analysis evaluates various treatments for retinitis pigmentosa (RP)-associated macular oedema. The study found that carbon…
Different medications show varying success in reducing swelling and improving vision for patients with retinitis pigmentosa-associated macul…
Dynamic gratings serve as tools for diagnosis and treatment evaluation in neuro-ophthalmic conditions
Dynamic gratings help doctors understand and treat eye conditions
This narrative review explores the use of dynamic gratings, such as phase-alternating oscillation and rapid serial visual presentation, to e…
Moving patterns on a screen, called dynamic gratings, offer new ways to study and treat vision issues like glaucoma and diabetic retinopathy…